06/27/2025 3:25 PM | Portage Biotech (Filer)
| Form 424B3 | |
06/25/2025 6:26 AM | Portage Biotech (Filer)
| Form 424B3 | |
06/25/2025 6:15 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/09/2025 6:00 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/09/2025 6:14 AM | Portage Biotech (Filer)
| Form 424B3 | |
05/29/2025 3:30 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2025 11:15 PM | Portage Biotech (Filer)
| Form EFFECT | |
04/28/2025 5:20 AM | Portage Biotech (Filer)
| Form 424B3 | |
04/28/2025 5:10 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025 3:37 PM | Portage Biotech (Filer)
| Form 424B3 | |
03/13/2025 3:34 PM | Portage Biotech (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for PRTG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter.
|
03/12/2025 7:20 AM | Portage Biotech (Filer)
| Form 424B3 | |
03/12/2025 7:10 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/12/2025 3:25 PM | Portage Biotech (Filer)
| Form 424B3 | |
02/12/2025 3:20 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/06/2025 5:00 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/06/2025 5:12 AM | Portage Biotech (Filer)
| Form 424B3 | |
12/19/2024 3:43 PM | Mellon James (Filed by) Portage Biotech (Subject)
| Form SCHEDULE 13D/A | |
12/17/2024 6:05 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024 6:11 AM | Portage Biotech (Filer)
| Form 424B3 | |
12/13/2024 3:35 PM | Portage Biotech (Filer)
| Form 424B3 | |
12/13/2024 3:15 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2024 4:01 PM | Portage Biotech (Filer)
| Form 424B3 | |
12/12/2024 3:30 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2024 3:35 PM | Portage Biotech (Filer)
| Form 424B3 | |
12/05/2024 3:28 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/26/2024 3:47 PM | Portage Biotech (Filer)
| Form 424B3 | |
11/26/2024 3:25 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024 3:26 PM | ARMISTICE CAPITAL, LLC (Filed by) Portage Biotech (Subject)
| Form SC 13G/A | |
10/04/2024 3:30 PM | Portage Biotech (Filer)
| Form 424B3 | |
10/04/2024 3:15 PM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2024 8:18 PM | Portage Biotech (Subject) Shaw Allan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 3:28 PM | Portage Biotech (Subject) Shaw Allan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/23/2024 8:41 AM | MINTZ STEVEN (Reporting) Portage Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024 10:25 AM | Bailey Gregory (Reporting) Portage Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024 11:15 PM | Portage Biotech (Filer)
| Form EFFECT | |
08/27/2024 7:30 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024 5:05 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2024 5:11 AM | Portage Biotech (Filer)
| Form 424B3 | |
08/15/2024 7:31 AM | Portage Biotech (Filer)
| Form 424B3 | |
08/15/2024 7:00 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
A grave, grave error. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
08/14/2024 4:29 PM | Portage Biotech (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
08/13/2024 7:52 AM | Portage Biotech (Filer)
| Form 424B3 | |
08/13/2024 7:00 AM | Portage Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024 3:31 PM | Portage Biotech (Filer)
| Form 424B3 | |